ABRAXIS PHARM Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABRAXIS PHARM
ABRAXIS PHARM has one hundred and thirteen approved drugs.
Summary for ABRAXIS PHARM
| US Patents: | 0 |
| Tradenames: | 64 |
| Ingredients: | 60 |
| NDAs: | 113 |
Drugs and US Patents for ABRAXIS PHARM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | AMPHOTERICIN B | amphotericin b | INJECTABLE;INJECTION | 062728-001 | Apr 13, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Abraxis Pharm | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 062688-003 | Nov 17, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Abraxis Pharm | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 086761-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Abraxis Pharm | NANDROLONE DECANOATE | nandrolone decanoate | INJECTABLE;INJECTION | 088317-001 | Oct 14, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Abraxis Pharm | CYANOCOBALAMIN | cyanocobalamin | INJECTABLE;INJECTION | 080510-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
